Alan Karp
Gastroenterology · El Paso, TXNPI 1982696324
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,842 and has fallen 97.6% since, to $44 in 2024.
Across 345 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$932
- Takeda Pharmaceuticals U.S.A., Inc.$721
- Johnson & Johnson$538
- Pfizer$453
- Intercept Pharmaceuticals, Inc.$338
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,03699%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,292 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 57 | $932 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $721 |
| Johnson & Johnson | 38 | $538 |
| Pfizer | 44 | $453 |
| Intercept Pharmaceuticals, Inc. | 18 | $338 |
| Gilead | 16 | $327 |
| Daiichi Sankyo Inc. | 18 | $260 |
| Merck | 17 | $238 |
| Ferring Pharmaceuticals Inc. | 4 | $180 |
| Nestle Healthcare Nutrition Inc. | 7 | $130 |
| Medtronic | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 1 | $95 |
| Ironwood Pharmaceuticals, Inc | 4 | $75 |
| Shire North American Group Inc | 5 | $64 |
| Pharming Healthcare, Inc. | 2 | $52 |
| Ambu Inc. | 2 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Ardelyx, Inc. | 2 | $38 |
| Bristol Myers Squibb | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 2 | $25 |
| Amgen | 1 | $25 |
| Endogastric Solutions, Inc | 2 | $21 |
| Redhill Biopharma Inc. | 1 | $18 |
| UCB, Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,088 in reported general payments places this provider in the 65th percentile of 1,350 gastroenterology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 24 | $792 |
| Pantoprazole Sodium | 14 | $371 |
| Omeprazole | 21 | $299 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in El Paso
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
- Brooks CashHouston$867K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.